Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OranssiBio
Shanghai, Shanghai Municipality, Chinaoranssibio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
OranssiBio is an active CDMO specializing in high-end research, development, and GMP manufacturing services for cell and gene therapies. The company leverages advanced technologies including exosomes, viral vectors, plasmid DNA, mAbs, and small molecules. It provides comprehensive solutions supporting discovery through commercialization with global regulatory compliance. No direct clinical results are reported since it is primarily a service provider rather than a therapeutic developer.[1][2][5][7][9]
- Modalities
- ExosomesAdeno-associated virus (AAV)LentivirusCell therapiesPlasmid DNAMonoclonal antibodies (mAbs)Small molecules
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on OranssiBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OranssiBio.